Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: EDARAVONE — Original Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

The FDA approved the Original Application for edaravone from XGen Pharmaceuticals DJB, Inc., enabling a generic version of the ALS therapy to reach the U.S. mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edaravone (Edaravone)

Snippet

ORIG AP for EDARAVONE (EDARAVONE)